N/A N=10 Treatment

Ultrasound Device for Hair Removal

Hair Removal

Bottom Line

View on ClinicalTrials.gov: NCT01057134 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Sep 2023

Primary outcome: Primary: Reduction in Hair Count in the Treated Area — 13.1; 10.7; 18.7 percentage of hair reduction

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Cutera Ultrasound Device (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Cutera Inc.
Primary completion: Mar 2011

Outcome Measures

Outcome	Result	p-value
PRIMARY Reduction in Hair Count in the Treated Area	13.1; 10.7; 18.7	—

Summary

The purpose of this study is to evaluate the safety and efficacy of the Cutera UHAIR ultrasound device for hair removal.

Eligibility Criteria

Inclusion Criteria

Male or female at least 18 years of age
Fitxpatrick skin type I-IV
Area with unwanted hair
Subject must be able to read, understand and sign the consent form
Subject must adhere to the follow-up schedule and study instruction

Exclusion Criteria

Simultaneous participation in any other clinical study
Inability or unwillingness to follow the treatment schedule
Inability or unwillingness to sign the informed consent
Infection in the target area
Any disease or condition that could impair wound healing
History of keloid formation
History of malignant tumors in the target area
Skin abnormalities in the target area, e.g. cuts, scrapes, wounds, scars, large moles
History of hair removal in target area (light based or electrolysis)
Pregnant or lactating

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01057134). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.